Goat Anti-Human IgA alpha chain (HRP) (ab97215)
Key features and details
- Goat Anti-Human IgA alpha chain (HRP)
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ELISA, WB, ICC
Related conjugates and formulations
製品の概要
-
製品名
Goat Anti-Human IgA alpha chain (HRP)
IgA 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Human -
特異性
By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgA. Cross reactivity with other immunoglobulins and light chains is less than 0.1%. -
アプリケーション
適用あり: IHC-P, ELISA, WB, ICCmore details -
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase (HRP). -
特記事項(標識)
Molar enzyme/ antibody protein ratio is 4:1 -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab97215の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IHC-P |
1/200 - 1/2000.
|
|
ELISA | (1) |
1/10000 - 1/100000. Primary.
|
WB |
1/2000 - 1/25000. Colorimetric 1/2000 - 1/20000; Chemiluminescent 1/5000 - 1/25000
|
|
ICC |
Use at an assay dependent dilution.
|
特記事項 |
---|
IHC-P
1/200 - 1/2000. |
ELISA
1/10000 - 1/100000. Primary. |
WB
1/2000 - 1/25000. Colorimetric 1/2000 - 1/20000; Chemiluminescent 1/5000 - 1/25000 |
ICC
Use at an assay dependent dilution. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (28)
ab97215 は 28 報の論文で使用されています。
- Xu T et al. Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren's syndrome. JCI Insight 8:N/A (2023). PubMed: 36881472
- Gonçalves J et al. Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection. JCI Insight 8:N/A (2023). PubMed: 37490342
- Canto E Castro L et al. Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection. Eur J Immunol 52:149-160 (2022). PubMed: 34695227
- Ren C et al. Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients. Front Microbiol 13:782421 (2022). PubMed: 35283823
- Lv JM et al. Evaluation of Proanthocyanidins from Kiwi Leaves (Actinidia chinensis) against Caco-2 Cells Oxidative Stress through Nrf2-ARE Signaling Pathway. Antioxidants (Basel) 11:N/A (2022). PubMed: 35883858